Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma.

Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Habrand JL, Alapetite C, Coche-Dequeant B, Bernier V, Claude L, Carrie C, Padovani L, Muracciole X, Supiot S, Huchet A, Leseur J, Kerr C, Hangard G, Lisbona A, Goudjil F, Ferrand R, Laprie A.

Front Oncol. 2019 Jun 21;9:531. doi: 10.3389/fonc.2019.00531. eCollection 2019.

2.

Re-irradiation of locally recurrent pediatric intracranial ependymoma: Experience of the French society of children's cancer.

Régnier E, Laprie A, Ducassou A, Bolle S, Supiot S, Muracciole X, Claude L, Chapet S, Coche-Dequéant B, Vigneron C, Leseur J, Bondiau PY, Habrand JL, Bernier V.

Radiother Oncol. 2019 Mar;132:1-7. doi: 10.1016/j.radonc.2018.11.009. Epub 2018 Dec 20.

PMID:
30825956
3.

Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.

Oudard S, Latorzeff I, Caty A, Miglianico L, Sevin E, Hardy-Bessard AC, Delva R, Rolland F, Mouret L, Priou F, Beuzeboc P, Gravis G, Linassier C, Gomez P, Voog E, Muracciole X, Abraham C, Banu E, Ferrero JM, Ravaud A, Krakowski I, Lagrange JL, Deplanque G, Zylberait D, Bozec L, Houede N, Culine S, Elaidi R.

JAMA Oncol. 2019 May 1;5(5):623-632. doi: 10.1001/jamaoncol.2018.6607.

PMID:
30703190
4.

Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population.

Muracciole X, El-Amine W, Tabouret E, Boucekine M, Barlier A, Petrirena G, Harivony T, Solignac L, Chinot OL, Macagno N, Figarella-Branger D, Padovani L.

Front Oncol. 2018 Oct 4;8:426. doi: 10.3389/fonc.2018.00426. eCollection 2018.

5.

Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact.

Houvenaeghel G, de Nonneville A, Cohen M, Classe JM, Reyal F, Mazouni C, Chopin N, Martinez A, Daraï E, Coutant C, Colombo PE, Gimbergues P, Chauvet MP, Azuar AS, Rouzier R, de Lara CT, Muracciole X, Agostini A, Gonçalves A, Lambaudie E.

Breast Cancer Res Treat. 2019 Jan;173(1):111-122. doi: 10.1007/s10549-018-4944-2. Epub 2018 Sep 20.

PMID:
30238274
6.

Immunologically effective dose: a practical model for immuno-radiotherapy.

Serre R, Barlesi F, Muracciole X, Barbolosi D.

Oncotarget. 2018 Aug 7;9(61):31812-31819. doi: 10.18632/oncotarget.25746. eCollection 2018 Aug 7.

7.

Pediatric Localized Intracranial Ependymomas: A Multicenter Analysis of the Société Française de lutte contre les Cancers de l'Enfant (SFCE) from 2000 to 2013.

Ducassou A, Padovani L, Chaltiel L, Bolle S, Habrand JL, Claude L, Carrie C, Muracciole X, Coche-Dequeant B, Alapetite C, Supiot S, Demoor-Goldschmidt C, Bernier-Chastagner V, Huchet A, Leseur J, Le Prise E, Kerr C, Truc G, Nguyen TD, Bertozzi AI, Frappaz D, Boetto S, Sevely A, Tensaouti F, Laprie A; Pediatric French Radiation Oncologist Group (GFRP) and the French Society of Children With Cancer (SFCE).

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):166-173. doi: 10.1016/j.ijrobp.2018.05.036. Epub 2018 May 24.

PMID:
30102193
8.

Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial.

de Crevoisier R, Bayar MA, Pommier P, Muracciole X, Pêne F, Dudouet P, Latorzeff I, Beckendorf V, Bachaud JM, Laplanche A, Supiot S, Chauvet B, Nguyen TD, Bossi A, Créhange G, Lagrange JL.

Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1420-1429. doi: 10.1016/j.ijrobp.2018.07.2006. Epub 2018 Jul 31.

PMID:
30071296
9.

Hippocampal Sparing During Craniospinal Irradiation: What Did We Learn About the Incidence of Perihippocampus Metastases?

Padovani L, Chapon F, André N, Boucekine M, Geoffray A, Bourdeau F, Masliah-Planchon J, Claude L, Huchet A, Laprie A, Supiot S, Coche-Dequéant B, Kerr C, Alapetite C, Leseur J, Nguyen T, Chapet S, Bernier V, Bondiau PY, Noel G, Habrand JL, Bolle S, Doz F, Dufour C, Muracciole X, Carrie C.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):980-986. doi: 10.1016/j.ijrobp.2017.12.265. Epub 2017 Dec 21.

PMID:
29485078
10.

Coxiella burnetii Lipopolysaccharide: What Do We Know?

Abnave P, Muracciole X, Ghigo E.

Int J Mol Sci. 2017 Nov 23;18(12). pii: E2509. doi: 10.3390/ijms18122509. Review.

11.

Macrophages in Invertebrates: From Insects and Crustaceans to Marine Bivalves.

Abnave P, Muracciole X, Ghigo E.

Results Probl Cell Differ. 2017;62:147-158. doi: 10.1007/978-3-319-54090-0_6. Review.

PMID:
28455708
12.

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study.

de Nonneville A, Gonçalves A, Zemmour C, Classe JM, Cohen M, Lambaudie E, Reyal F, Scherer C, Muracciole X, Colombo PE, Giard S, Rouzier R, Villet R, Chopin N, Darai E, Garbay JR, Gimbergues P, Sabiani L, Coutant C, Sabatier R, Bertucci F, Boher JM, Houvenaeghel G.

Breast Cancer Res Treat. 2017 Apr;162(2):307-316. doi: 10.1007/s10549-017-4136-5. Epub 2017 Feb 2.

PMID:
28155054
13.

Patterns of failure after radiotherapy for pediatric patients with intracranial ependymoma.

Tensaouti F, Ducassou A, Chaltiel L, Bolle S, Muracciole X, Coche-Dequeant B, Alapetite C, Bernier V, Claude L, Supiot S, Huchet A, Kerr C, le Prisé E, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE).

Radiother Oncol. 2017 Mar;122(3):362-367. doi: 10.1016/j.radonc.2016.12.025. Epub 2017 Jan 12.

PMID:
28089483
14.

Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study.

Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Muracciole X, Coche-Dequant B, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Payoux P, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE).

Br J Radiol. 2016 Oct;89(1066):20160537. doi: 10.1259/bjr.20160537. Epub 2016 Aug 23.

15.

[French organization of paediatric radiation treatment: Results of a survey conducted by the radiotherapy Committee of the French Society of Paediatric Cancers (SFCE)].

Demoor-Goldschmidt C, Claude L, Carrie C, Bolle S, Helfre S, Alapetite C, Jouin A, Padovani L, Ducassou A, Vigneron C, Le Prisé É, Huchet A, Stefan D, Kerr C, Nguyen TD, Truc G, Chapet S, Bondiau PY, Coche B, Muracciole X, Laprie A, Noël G, Leseur J, Habrand JL, Potet H, Ruffier A, Supiot S, Mahé MA, Bernier V.

Cancer Radiother. 2016 Jul;20(5):395-9. doi: 10.1016/j.canrad.2016.05.016. Epub 2016 Jul 13. French.

PMID:
27421622
16.

[French experience in paediatric total body irradiation: A study from the radiotherapy committee of the Société française des cancers de l'enfant (SFCE)].

Demoor-Goldschmidt C, Supiot S, Claude L, Carrie C, Mazeron R, Helfré S, Alapetite C, Jouin A, Coche B, Padovani L, Muracciole X, Bernier V, Vigneron C, Noël G, Leseur J, Le Prisé É, Stefan D, Habrand JL, Kerr C, Bondiau PY, Ruffier A, Chapet S, Mahé MA.

Cancer Radiother. 2016 Jun;20(4):304-7. doi: 10.1016/j.canrad.2016.02.011. Epub 2016 Jun 21. French.

PMID:
27342946
17.

Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy.

Serre R, Benzekry S, Padovani L, Meille C, André N, Ciccolini J, Barlesi F, Muracciole X, Barbolosi D.

Cancer Res. 2016 Sep 1;76(17):4931-40. doi: 10.1158/0008-5472.CAN-15-3567. Epub 2016 Jun 14.

18.

An alternative parameter for early forecasting clinical response in NSCLC patients during radiotherapy: proof of concept study.

Padovani L, Baret A, Ciccolini J, Taieb D, Bardia F, Teissonnier L, Muracciole X, Barlesi F, Barbolosi D.

Br J Radiol. 2016 Jun;89(1062):20160061. doi: 10.1259/bjr.20160061. Epub 2016 Apr 4.

19.

Multicentre randomised phase II trial of gemcitabine+platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2.

Oudard S, Culine S, Vano Y, Goldwasser F, Théodore C, Nguyen T, Voog E, Banu E, Vieillefond A, Priou F, Deplanque G, Gravis G, Ravaud A, Vannetzel JM, Machiels JP, Muracciole X, Pichon MF, Bay JO, Elaidi R, Teghom C, Radvanyi F, Beuzeboc P.

Eur J Cancer. 2015 Jan;51(1):45-54. doi: 10.1016/j.ejca.2014.10.009. Epub 2014 Nov 15.

PMID:
25459391
20.

[Comparative study of radical prostatectomy versus external beam radiotherapy (75.6 Gy) combined with hormone therapy for prostate cancer of intermediate D'Amico risk classification].

Boissier R, Karsenty G, Muracciole X, Daniel L, Delaporte V, Maurin C, Coulange C, Lechevallier E.

Prog Urol. 2013 Sep;23(10):861-8. doi: 10.1016/j.purol.2013.04.007. Epub 2013 May 13. French.

PMID:
24034798
21.

Cost of prostate image-guided radiation therapy: results of a randomized trial.

Perrier L, Morelle M, Pommier P, Lagrange JL, Laplanche A, Dudouet P, Supiot S, Chauvet B, Nguyen TD, Crehange G, Beckendorf V, Pene F, Muracciole X, Bachaud JM, Le Prisé E, de Crevoisier R.

Radiother Oncol. 2013 Jan;106(1):50-8. doi: 10.1016/j.radonc.2012.11.011. Epub 2013 Jan 17.

22.

Neurocognitive function after radiotherapy for paediatric brain tumours.

Padovani L, André N, Constine LS, Muracciole X.

Nat Rev Neurol. 2012 Oct;8(10):578-88. doi: 10.1038/nrneurol.2012.182. Epub 2012 Sep 11. Review.

PMID:
22964509
23.

[Prospective economic evaluation of image-guided radiation therapy for prostate cancer in the framework of the national programme for innovative and costly therapies assessment].

Pommier P, Morelle M, Perrier L, de Crevoisier R, Laplanche A, Dudouet P, Mahé MA, Chauvet B, Nguyen TD, Créhange G, Zawadi A, Chapet O, Latorzeff I, Bossi A, Beckendorf V, Touboul E, Muracciole X, Bachaud JM, Supiot S, Lagrange JL.

Cancer Radiother. 2012 Sep;16(5-6):444-51. doi: 10.1016/j.canrad.2012.07.178. Epub 2012 Aug 27. French.

PMID:
22951488
24.

[Treatment of trigeminal neuralgia with radiosurgery].

Latorzeff I, Debono B, Sol JC, Ménégalli D, Mertens P, Redon A, Muracciole X.

Cancer Radiother. 2012 Jun;16 Suppl:S57-69. doi: 10.1016/j.canrad.2012.01.007. Epub 2012 Jun 6. Review. French.

PMID:
22682396
25.

γ knife radiosurgery of brain metastasis from breast cancer.

Padovani L, Muracciole X, Régis J.

Prog Neurol Surg. 2012;25:156-62. doi: 10.1159/000331189. Epub 2012 Jan 6. Review.

PMID:
22236677
26.

Reirradiation and concomitant metronomic temozolomide: an efficient combination for local control in medulloblastoma disease?

Padovani L, Andre N, Gentet JC, Figarella Branger D, Scavarda D, Verschuur A, Chinot O, Cowen D, Muracciole X.

J Pediatr Hematol Oncol. 2011 Dec;33(8):600-4. doi: 10.1097/MPH.0b013e3182331eaf.

PMID:
22042276
27.

Medulloblastoma.

Padovani L, André N, Gentet JC, Muracciole X.

Eur J Cancer. 2011 Sep;47 Suppl 3:S338. doi: 10.1016/S0959-8049(11)70194-0. No abstract available.

PMID:
21944006
28.

Breast cancer--what about radiosurgery for brain metastasis?

Padovani L, Regis JM, Muracciole X.

Nat Rev Clin Oncol. 2011 Jul 12;8(8):506; author reply 506. doi: 10.1038/nrclinonc.2011.119-c1. No abstract available.

PMID:
21750503
29.

Associated is not induced!

Régis J, Muracciole X.

World Neurosurg. 2010 Jun;73(6):642-3. doi: 10.1016/j.wneu.2010.05.045. No abstract available.

PMID:
20934150
30.

[Childhood and adult medulloblastoma: what difference?].

Padovani L, André N, Carrie C, Muracciole X.

Cancer Radiother. 2009 Oct;13(6-7):530-5. doi: 10.1016/j.canrad.2009.06.024. Epub 2009 Aug 26. French.

PMID:
19713143
31.

Inter-clinician variability in making dosimetric decisions in pediatric treatment: a balance between efficacy and late effects.

Padovani L, Huchet A, Claude L, Bernier V, Quetin P, Mahe M, Laprie A, Kerr C, Bondiau PY, Delarue A, Coze C, Gibon D, Barteau C, Maire JP, Carrie C, Muracciole X.

Radiother Oncol. 2009 Nov;93(2):372-6. doi: 10.1016/j.radonc.2009.05.024. Epub 2009 Aug 3.

PMID:
19647884
32.

Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.

Deville JL, Bartoli C, Berenguer C, Fernandez-Sauze S, Kaafarani I, Delfino C, Fina F, Salas S, Muracciole X, Mancini J, Lechevallier E, Martin PM, Figarella-Branger D, Ouafik L, Daniel L.

Int J Cancer. 2009 Nov 15;125(10):2307-15. doi: 10.1002/ijc.24568.

33.

Radiosurgery and carcinogenesis risk.

Muracciole X, Régis J.

Prog Neurol Surg. 2008;21:207-213. doi: 10.1159/000157166. Review.

PMID:
18810221
34.

Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.

Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, Ouafik L.

Oncogene. 2008 Jan 17;27(4):506-18. Epub 2007 Jul 16.

PMID:
17637748
35.

Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults.

Padovani L, Sunyach MP, Perol D, Mercier C, Alapetite C, Haie-Meder C, Hoffstetter S, Muracciole X, Kerr C, Wagner JP, Lagrange JL, Maire JP, Cowen D, Frappaz D, Carrie C.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):433-40.

PMID:
17498567
36.

Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.

Chinot OL, Barrié M, Fuentes S, Eudes N, Lancelot S, Metellus P, Muracciole X, Braguer D, Ouafik L, Martin PM, Dufour H, Figarella-Branger D.

J Clin Oncol. 2007 Apr 20;25(12):1470-5.

PMID:
17442989
37.

[High risk prostate cancer results of one year RT-HT].

Delaporte V, Muracciole X, Lechevalier E, Bastide C, Cowen D, Rossi D, Coulange C.

Prog Urol. 2005 Dec;15(6 Suppl 1):1256-61. French. No abstract available.

PMID:
16734214
38.

Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy.

Gaudy-Marqueste C, Regis JM, Muracciole X, Laurans R, Richard MA, Bonerandi JJ, Grob JJ.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):809-16. Epub 2006 May 6.

PMID:
16682138
39.

Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy.

Metellus P, Regis J, Muracciole X, Fuentes S, Dufour H, Nanni I, Chinot O, Martin PM, Grisoli F.

Neurosurgery. 2005 Nov;57(5):873-86; discussion 873-86.

PMID:
16284558
40.

Molecular profile of androgen-independent prostate cancer xenograft LuCaP 23.1.

Fina F, Muracciole X, Rocchi P, Nanni-Métellus I, Delfino C, Daniel L, Dussert C, Ouafik L', Martin PM.

J Steroid Biochem Mol Biol. 2005 Sep;96(5):355-65. Epub 2005 Jul 25.

PMID:
16043352
41.

[Prostate cancer at high risk of recurrence: results of 12 months of radiotherapy-hormone therapy].

Delaporte V, Muracciole X, Lechevallier E, Bastide C, Cowen D, Rossi D, Coulange C.

Prog Urol. 2005 Apr;15(2):260-4. French.

PMID:
15999604
42.

Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.

Carrie C, Muracciole X, Gomez F, Habrand JL, Benhassel M, Mege M, Mahé M, Quetin P, Maire JP, Soum F, Baron MH, Clavere P, Chapet S, Gaci Z, Kolodie H, Maingon P, Vie B, Bernier V, Alapetite C, Hoffstetter S, Grill J, Lafay F; French Society of Pediatric Oncology.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):711-6. Epub 2005 May 31.

PMID:
15927408
43.

Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme.

Barrié M, Couprie C, Dufour H, Figarella-Branger D, Muracciole X, Hoang-Xuan K, Braguer D, Martin PM, Peragut JC, Grisoli F, Chinot O.

Ann Oncol. 2005 Jul;16(7):1177-84. Epub 2005 Apr 27.

PMID:
15857844
44.

[Androgens and prostate: basic research and clinical data].

Martini PM, Rossi D, Muracciole X, Saussine C, Raynaud JP, Tostain J.

Prog Urol. 2004 Nov;14(5):751-67. Review. French. No abstract available.

PMID:
15747623
45.

Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft.

Rocchi P, Muracciole X, Fina F, Mulholland DJ, Karsenty G, Palmari J, Ouafik L, Bladou F, Martin PM.

Oncogene. 2004 Dec 2;23(56):9111-9.

PMID:
15489889
46.

[Radiosurgery and brain radio-induced carcinogenesis: update].

Muracciole X, Cowen D, Régis J.

Neurochirurgie. 2004 Jun;50(2-3 Pt 2):414-20. French.

PMID:
15179297
47.

Subcutaneous interleukin-2 and interferon alfa administration in patients with metastatic renal cell carcinoma: final results of SCAPP III, a large, multicenter, phase II, nonrandomized study with sequential analysis design--the Subcutaneous Administration Propeukin Program Cooperative Group.

Tourani JM, Pfister C, Tubiana N, Ouldkaci M, Prevot G, Lucas V, Oudard S, Malet M, Cottu P, Ferrero JM, Mayeur D, Rixe O, Sun XS, Bernard O, Andre T, Tournigand C, Muracciole X, Guilhot J; Subcutaneous Administration Propeukin Program Cooperative Group.

J Clin Oncol. 2003 Nov 1;21(21):3987-94.

PMID:
14581421
48.

Phase II study of oxaliplatin versus oxaliplatin combined with infusional 5-fluorouracil in hormone refractory metastatic prostate cancer patients.

Droz JP, Muracciole X, Mottet N, Ould Kaci M, Vannetzel JM, Albin N, Culine S, Rodier JM, Misset JL, Mackenzie S, Cvitkovic E, Benoit G.

Ann Oncol. 2003 Aug;14(8):1291-8.

PMID:
12881395
49.

Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior.

Daniel L, Bouvier C, Chetaille B, Gouvernet J, Luccioni A, Rossi D, Lechevallier E, Muracciole X, Coulange C, Figarella-Branger D.

Hum Pathol. 2003 Jun;34(6):528-32.

PMID:
12827605
50.

Impact of the model C and Automatic Positioning System on gamma knife radiosurgery: an evaluation in vestibular schwannomas.

Régis J, Hayashi M, Porcheron D, Delsanti C, Muracciole X, Peragut JC.

J Neurosurg. 2002 Dec;97(5 Suppl):588-91.

PMID:
12507102

Supplemental Content

Loading ...
Support Center